Literature DB >> 24493385

Laboratory tests during direct oral anticoagulant treatment.

Armando Tripodi1, Simon Braham, Marco Moia.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24493385     DOI: 10.1007/s11739-014-1051-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  6 in total

1.  Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.

Authors:  Theodore E Warkentin; Peter Margetts; Stuart J Connolly; Andre Lamy; Chris Ricci; John W Eikelboom
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

Review 2.  The laboratory and the direct oral anticoagulants.

Authors:  Armando Tripodi
Journal:  Blood       Date:  2013-04-05       Impact factor: 22.113

3.  Laboratory tests during direct oral anticoagulant treatment? No.

Authors:  Giovanni Di Minno; Elena Ricciardi; Antonella Scalera
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

4.  Laboratory tests during direct oral anticoagulant treatment? Yes.

Authors:  Vittorio Pengo
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

5.  European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Europace       Date:  2013-05       Impact factor: 5.214

6.  Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.

Authors:  Elise S Eerenberg; Pieter W Kamphuisen; Meertien K Sijpkens; Joost C Meijers; Harry R Buller; Marcel Levi
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

  6 in total
  1 in total

1.  Laboratory tests during direct oral anticoagulant treatment? Authors' reply.

Authors:  Giovanni Di Minno; Elena Ricciardi; Antonella Scalera
Journal:  Intern Emerg Med       Date:  2015-06-19       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.